newsfilter
← Latest News
Business Wire·

The Medicines Company Reports Second-Quarter 2019 Financial Results and Updates Clinical Development Program

PARSIPPANY, N.J.--(BUSINESS WIRE)--The Medicines Company (NASDAQ: MDCO) today reported financial results for the second quarter that ended June 30, 2019. Second quarter highlights included significant progress with the clinical development program for inclisiran and the completion of a public offering of common stock.